Obtaining an updated view of the epidemiology, risk factors, and prognosis of systemic lupus
erythematosus (SLE) is pivotal to our understanding of the disease burden. Recent …

Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disease with a
significant disease burden across the world among different ethnic, racial, and age groups …

SLE is a chronic autoimmune rheumatic disorder of high heterogeneity in clinical
presentation, treatment response and prognosis. Long-term outcomes in SLE have been …

Systemic lupus erythematosus (SLE) is an immune-mediated multi-systemic disease
characterized by a wide variability of clinical manifestations and a course frequently subject …

Systemic lupus erythematosus (SLE) is a devastating autoimmune disease that can result in
substantial morbidity and mortality. Diagnosis and treatment of SLE are clinical challenges …

Without a new medication approved for systemic lupus erythematosus (SLE) by the Food
and Drug Administration in more than 40 years, there has been a recent flurry of research …

Objectives To determine the trends in incidence, prevalence and mortality of systemic lupus
erythematosus (SLE) in a US population over four decades. Methods We identified all the …

Systemic lupus erythematosus (SLE) is a chronic multisystem auto-immune disease with
extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE …

Systemic lupus erythematosus (SLE) is a systemic autoimmune condition characterised by a
wide spectrum of clinical manifestations, partly related to the disease itself, but also linked to …

Introduction: Systemic lupus erythematosus (SLE) is a disease distributed worldwide, which
occurs in both genders, and across racial/ethnic and age groups; however, higher rates are …